FEATURE SESSION: Hosted by CPI

Revolutionising Medicines Manufacturing Takes Serious Collaboration Feature session - Hosted by CPI

Time & Location

Wednesday: 11.00 to 12.00, Stage 3

Hosted by CPI

Dr. Caroline KellyHead of Technology Strategy, Formulation

About this Session

If partnering has crossed your mind when looking at ways to accelerate your innovation but don’t know where to start, come along to learn how CPI is leveraging the power of partnerships to overcome some of the challenges to successful collaboration.

Through a Grand Challenge model, aimed at tackling the pharmaceutical industry’s largest problems, CPI’s Medicines Manufacturing Innovation Centre is working together with collaborators in a pre-competitive environment, to break down barriers previously limiting the ability and speed of new and innovative technology adoption.

  • Session coordinator: Neil Sheddan, Business Development Director, Medicines Manufacturing Innovation Centre at CPI

Speaker Bio:

CPI Pharma Capabilty Overview:

Dr Caroline Kelly earned her degree and PhD in Chemistry from University of Cambridge, UK, and has over 15 years’ experience in the chemical industry before joining CPI in 2016.

Her early career included technical roles in formulation science and product development at large corporates, such as Esso, ICI, and Croda, and latterly a UK start-up, giving her a wide breadth of cross-sector formulation knowledge and experience.  She then moved into a customer-facing role for a UK chemical distributor, being responsible for driving the technical development and growth of a portfolio of surfactants and blended products.

She joined CPI to manage a programme of strategic partnership projects between academia, industry, and supply chain partners to build new capability as part of the grant to develop CPI’s National Formulation Centre to ultimately support companies active in formulation within the UK, including capability to support the process development and scale-up of nanotherapeutics.  Her current role is to develop and lead the technology strategy for formulation within CPI.